Lasa Supergenerics Limited (NSE:LASA)
India · Delayed Price · Currency is INR 5.32
0.00 (0.00%)
Oct 5, 2026, 3:11 PM IST
Lasa Supergenerics Market Cap
Lasa Supergenerics has a market cap or net worth of 266.54 million as of October 7, 2026. That makes Lasa Supergenerics the world's 47,121st most valuable company and 4,460th in India. Its market cap has decreased by 54.76% in one year.
Market Cap
266.54M
Enterprise Value
357.04M
Revenue
65.20M
Global Rank
Country Rank
#4,460 India
PE Ratio
n/a
ChartMarket Cap Chart
Since September 22, 2017, Lasa Supergenerics's market cap has decreased from 3.53B to 266.54M, a decrease of -92.46%. That is a compound annual growth rate of -24.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 266.54M | -43.64% |
| Dec 31, 2025 | 472.96M | -62.89% |
| Dec 31, 2024 | 1.27B | -14.92% |
| Dec 29, 2023 | 1.50B | 9.45% |
| Dec 30, 2022 | 1.37B | -50.95% |
| Dec 31, 2021 | 2.79B | -18.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sigachi Industries | 10.97B |
| Bafna Pharmaceuticals | 8.96B |
| Amanta Healthcare | 7.39B |
| Valiant Laboratories | 6.79B |
| Nectar Lifesciences | 1.99B |
| Brooks Laboratories | 1.60B |
| Par Drugs and Chemicals | 1.53B |
| Alpa Laboratories | 1.25B |